Quantum Leap Healthcare Collaborative

I-SPY in the News

Widely hailed as the future of phase II drug development, the adaptive I-SPY2 platform trial has set a new benchmark for efficiency, through innovation in trial design and clinical operations.
I-SPY Email List Sign-up


Recent Coverage

October 26, 2016
Cancer Therapy Advisor
Adaptive randomization and the I-SPY 2 trial platform
September 5, 2016
Back to School: Haste, not waste
June 25, 2016
Oncology Times
I-SPY 2 shows efficacy of T-DM1-Pertuzumab
November 2, 2015
Managed Care Mag.
Can Platform Trials Speed Cancer Drug Development?
October 2, 2010
Wall St Journal
A new Rx for medicine